Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Ji-Eun Chang; Hyun-Jong Cho; Sanghoon Jheon

doi:10.3791/54865

Anticancer efficacité de la thérapie photodynamique avec Lung Cancer-ciblée Nanoparticules

JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Cancer Research

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer efficacité de la thérapie photodynamique avec Lung Cancer-ciblée Nanoparticules

Full Text

9,571 Views

08:03 min

December 1, 2016

DOI: 10.3791/54865-v

Ji-Eun Chang¹, Hyun-Jong Cho², Sanghoon Jheon^1,3

¹Department of Thoracic and Cardiovascular Surgery,Seoul National University Bundang Hospital, ²College of Pharmacy,Kangwon National University, ³Department of Thoracic and Cardiovascular Surgery,Seoul National University College of Medicine

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This study explores the enhancement of photodynamic therapy (PDT) for lung cancer treatment using lung cancer-targeted nanoparticles combined with chemotherapy. The efficacy of this approach was evaluated through both in vitro and in vivo studies.

Key Study Components

Area of Science

Oncology
Photodynamic Therapy
Nanotechnology

Background

Photodynamic therapy is a promising treatment for various cancers.
Targeted nanoparticles can improve the delivery of therapeutic agents.
Combining PDT with chemotherapy may enhance treatment efficacy.
Understanding agent conditions is crucial for effective therapy.

Purpose of Study

To increase the therapeutic effect of PDT in lung cancer.
To evaluate the efficacy of nanoparticles loaded with anticancer drugs.
To investigate the conditions for in vitro and in vivo studies.

Methods Used

Synthesis of hyaluronic acid ceramide.
Purification using a 3.5 kilodalton dialysis membrane.
Myophilization of the product.
Evaluation of anticancer efficacy in vitro and in vivo.

Main Results

Demonstrated enhanced therapeutic effects of PDT with nanoparticles.
Showed promising results in both in vitro and in vivo models.
Identified optimal conditions for PDT application.
Potential implications for treating other diseases beyond lung cancer.

Conclusions

PDT combined with targeted nanoparticles is a viable treatment strategy.
This approach may lead to improved outcomes in lung cancer therapy.
Further research is needed to explore broader applications.

Frequently Asked Questions

What is photodynamic therapy?

Photodynamic therapy (PDT) is a treatment that uses light-sensitive compounds to kill cancer cells when activated by light.

How do nanoparticles enhance PDT?

Nanoparticles can improve the delivery of photosensitizers and anticancer drugs directly to tumor sites, increasing treatment efficacy.

What are the benefits of combining PDT with chemotherapy?

Combining PDT with chemotherapy may enhance the overall therapeutic effect and improve patient outcomes in cancer treatment.

What conditions were evaluated in this study?

The study evaluated the proper agent conditions for both in vitro and in vivo studies of PDT.

Can this technique be used for other diseases?

Yes, the implications of this technique extend to other diseases such as tuberculosis and dermatological conditions.

What is the significance of using hyaluronic acid ceramide?

Hyaluronic acid ceramide is used to create targeted nanoparticles that can enhance the delivery of therapeutic agents to cancer cells.

La thérapie photodynamique (PDT) est un choix alternatif pour le traitement du cancer du poumon. Pour augmenter l’effet thérapeutique de la PDT, des nanoparticules ciblant le cancer du poumon combinées à une chimiothérapie ont été développées. L’efficacité anticancéreuse in vitro et in vivo de la PDT avec des nanoparticules préparées a été évaluée.

L’objectif global de cette expérience est d’augmenter l’effet thérapeutique de la thérapie photodynamique dans le traitement du cancer du poumon en utilisant à la fois des nanoparticules photosensibilisantes et anticancéreuses chargées de médicaments ciblant le cancer du poumon. Cette méthode peut aider à répondre à des questions clés dans le domaine de la thérapie photodynamique, telles que quelles sont les conditions appropriées de l’agent pour les études in vitro et in vivo. Étant donné que les thérapies photodynamiques sont largement utilisées dans les domaines du cancer, des études précancéreuses avec des photosensibilisants normaux ou de nouvelles indications peuvent être effectuées avec cette technique.

Les implications de cette technique se sont étendues au traitement de diverses maladies telles que la tuberculose, les ulcères et les domaines de dermatologie utilisant différents modules annuels. Pour commencer, synthétisez la céramide d’acide hyaluronique comme décrit dans le protocole de texte ci-joint. Purifier le produit à l’aide d’une membrane de dialyse de 3,5 kilodaltons et le myophaliser.

View the full transcript and gain access to thousands of scientific videos

Explore More Videos

Recherche Issue 118 thérapie photodynamique Nanoparticules cancer du poumon phototoxicité A549 BALB / C Nude Souris Cancer